Fulgent Genetics Inc. (FLGT) is scheduled to report third-quarter 2025 financial results before the market opens today, November 7, 2025.
This technology-based company operates in two segments - a well-established laboratory services business and a therapeutic development business.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com